Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The blood vessel endothelial cell membrane is a specialized lipid bilayer that forms the innermost lining of all blood vessels, acting as a dynamic interface between the blood and underlying tissues [1]. It functions as a selective permeability barrier, regulating the passage of nutrients, gases, and signaling molecules while preventing the uncontrolled extravasation of blood components [2]. The membrane is densely populated with receptors, such as Vascular Endothelial Growth Factor Receptors (VEGFRs), and adhesion molecules like ICAM-1 and VCAM-1, which are essential for angiogenesis and leukocyte recruitment during inflammation [3]. In diseases like atherosclerosis and diabetes, endothelial dysfunction leads to increased membrane permeability and a pro-thrombotic state [1, 4]. Pharmacological interventions often target specific proteins embedded within this membrane; for instance, monoclonal antibodies like bevacizumab inhibit VEGF signaling to suppress tumor angiogenesis [3]. Additionally, drugs like statins and nitroglycerin modulate endothelial membrane-associated enzymes to improve vascular tone and reduce inflammation [1]. Because the membrane is a complex cellular structure rather than a single molecular entity, it is often categorized as a site of action for various targeted therapies rather than a single target itself [2]. Citations: [1] StatPearls, Endothelial Dysfunction (2023); [2] Journal of Anatomy, The Vascular Endothelium (2005); [3] Cold Spring Harbor Perspectives in Medicine, VEGF and the Endothelium (2012); [4] Frontiers in Cardiovascular Medicine, Biomarkers of Endothelial Dysfunction (2021).
Modulation of vascular signaling pathways, including inhibition of growth factor receptors (e.g., VEGFR), activation of endothelial nitric oxide synthase (eNOS), and regulation of the coagulation cascade and leukocyte adhesion molecules.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood vessel endothelial cell membrane.